PT Multi Indocitra (MICE) Fundamentals 2026 — P/E 7.6x, Revenue Analysis | SniperIQ
PT Multi Indocitra (MICE) is a ID-listed Consumer Defensive company in Household & Personal Products with a market capitalization of Rp312.0B, trading at Rp520.00 on the JKT. This SniperIQ fundamentals page covers PT Multi Indocitra's valuation (P/E 7.6x, P/B 0.3x), profitability (net margin 3.1%), revenue (Rp1.21T in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is PT Multi Indocitra's market cap?
PT Multi Indocitra (MICE) has a market capitalization of approximately Rp312.0B, trading at Rp520.00 on the JKT. Market cap moves with the live share price.
What is PT Multi Indocitra's P/E ratio?
PT Multi Indocitra's trailing twelve-month P/E ratio is 7.6x, with a price-to-book (P/B) of 0.3x. Valuation multiples are best compared with Consumer Defensive sector peers rather than read in isolation.
How profitable is PT Multi Indocitra?
PT Multi Indocitra runs a net profit margin of 3.1%, a gross margin of 48.5%, and an operating margin of 2.0%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does PT Multi Indocitra generate?
PT Multi Indocitra reported revenue of Rp1.21T for fiscal year 2025, with net income of Rp43.6B and earnings per share (EPS) of 73.35. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does PT Multi Indocitra pay a dividend?
PT Multi Indocitra offers a trailing dividend yield of about 1.9%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is PT Multi Indocitra financially healthy?
PT Multi Indocitra carries a debt-to-equity ratio of 0.34x and a current ratio of 1.70x, with a market beta of 0.24. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is PT Multi Indocitra a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For PT Multi Indocitra (MICE) the key facts are: market cap Rp312.0B, P/E 7.6x, revenue Rp1.21T, 52-week range 450-810. Weigh valuation, profitability, growth, and balance-sheet strength against Consumer Defensive peers and form your own view.
Track PT Multi Indocitra's full fundamentals live
Get PT Multi Indocitra's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.